Why the study?
Does IKZF1 deletion predict prognosis in patients with acute lymphoblastic leukemia?
Does IKZF1 deletion predict prognosis in patients with acute lymphoblastic leukemia?
IKZF1 deletion is an independent predictive prognostic factor in acute lymphoblastic leukemia.
Answers are grounded in this paper and cite their sources.
Supports risk-adapted therapy in ALL; confirms IKZF1 deletion as independent prognostic factor.
The findings from this meta-analysis suggest that IKZF1 deletion can be used to serve as an independent predictive factor in patients with ALL.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: